210 related articles for article (PubMed ID: 3798124)
1. Megestrol acetate: first-line therapy for advanced breast cancer.
Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
[TBL] [Abstract][Full Text] [Related]
2. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
[TBL] [Abstract][Full Text] [Related]
3. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
Brufman G; Isacson R; Haim N; Gez E; Sulkes A
Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
[TBL] [Abstract][Full Text] [Related]
4. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
[TBL] [Abstract][Full Text] [Related]
5. Progestational agents in advanced breast cancer: an overview.
Haller DG; Glick JH
Semin Oncol; 1986 Dec; 13(4 Suppl 4):2-8. PubMed ID: 3026051
[TBL] [Abstract][Full Text] [Related]
6. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
Tchekmedyian NS; Tait N; Aisner J
Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG
Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078
[TBL] [Abstract][Full Text] [Related]
9. Sequential hormone therapy for advanced breast cancer.
Von Roenn JH; Bonomi PD; Gale M; Anderson KM; Wolter JM; Economou SG
Semin Oncol; 1988 Apr; 15(2 Suppl 1):38-43. PubMed ID: 3368799
[TBL] [Abstract][Full Text] [Related]
10. An overview of megestrol acetate for the treatment of advanced breast cancer.
Sedlacek SM
Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
[TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
Pronzato P; Brema F; Amoroso D; Bertelli G; Conte PF; Martini MC; Pastorino G; Rosso R
Breast Cancer Res Treat; 1990 Nov; 17(1):51-4. PubMed ID: 2095927
[TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Morgan LR
Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
[TBL] [Abstract][Full Text] [Related]
13. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
[TBL] [Abstract][Full Text] [Related]
14. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.
Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV
J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230
[TBL] [Abstract][Full Text] [Related]
15. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
[TBL] [Abstract][Full Text] [Related]
16. Overview of hormonal therapy in advanced breast cancer.
Schacter LP; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
Semin Oncol; 1990 Dec; 17(6 Suppl 9):38-46. PubMed ID: 2148026
[TBL] [Abstract][Full Text] [Related]
17. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
[TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate in advanced breast carcinoma.
Espie M
Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen.
Ross MB; Buzdar AU; Blumenschein GR
Cancer; 1982 Feb; 49(3):413-7. PubMed ID: 6174195
[TBL] [Abstract][Full Text] [Related]
20. Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
Crawford DJ; George WD; Smith DC; Stewart M; Paul J; Leake RE
Oncology; 1994 Oct; 51 Suppl 1():13-8. PubMed ID: 7970503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
